On Tuesday, Acorda Therapeutics CEO Ron Cohen appeared on “Mad Money” to offer insight on his company’s multiple sclerosis drug "AMPYRA.”
To Cramer, the drug could be a huge driver for the stock . But he wanted to get the perspective of the company’s CEO, so he was happy to chat with Cohen. Watch the video to see the full interview.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the Mad Money website? firstname.lastname@example.org